In Polish families, with a strong aggregation of breast and ovarian cancers and no other cancer, the frequency of BRCA2 mutations is very low and does not exceed 5–10% (van der Looij et al, 2000; Grzybowska et al, 2000; Górski unpublished data). This evidence concerns the gene BRCA2 and ovarian carcinoma.